The development of accurate, minimally invasive techniques that can detect cancers early and track recurrence is essential to driving treatment options for precision medicine. An international team of investigators led by scientists at Queen Mary University of London and Barts Health NHS Trust has developed just such a method, which can detect tiny amounts of circulating cancer DNA to identify the risk of cancer recurrence and guide precision treatment in bladder cancer following surgery.